Defunct Company
Total Trials
38
As Lead Sponsor
33
As Collaborator
5
Total Enrollment
11,879
NCT00731432
Herbal Periodontal Patch (THPP) for Gingival Inflammation in Diabetics
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2008
Completion: Not specified
NCT00918177
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
Start: Jul 31, 2009
NCT01196650
Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep
Start: Sep 30, 2010
NCT01277107
A Polysomnographic Study to Compare the Efficacy of Gastric Retentive Zaleplon Accordion Pill to Placebo in Subjects With Insomnia
Start: Jan 31, 2011
Completion: Sep 30, 2011
NCT01400620
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Start: Mar 31, 2012
Completion: Jan 31, 2017
NCT01427569
Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers
Completion: Aug 31, 2015
NCT00947037
Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study
Start: Aug 31, 2012
NCT02408731
A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers
Phase: Phase 1
Start: Oct 31, 2014
Completion: Apr 30, 2015
NCT02313545
Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV
Phase: Phase 1/2
Start: Dec 31, 2014
Completion: Mar 31, 2017
NCT02431533
The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome
Phase: N/A
Start: Jan 31, 2016
Completion: Aug 31, 2018
NCT02605434
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
Phase: Phase 3
Start: Mar 31, 2016
Completion: Dec 31, 2019
NCT02615873
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Start: Jul 31, 2016
NCT02852551
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects
Completion: Nov 30, 2016
NCT04056065
PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock
Start: May 29, 2017
Completion: Oct 21, 2018
NCT04046484
PMZ-1620 (Sovateltide) in Acute Ischemic Stroke Patients
Start: Jan 19, 2018
Completion: Jun 30, 2019
NCT04052737
PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease
Start: Mar 23, 2018
Completion: Jan 6, 2023
NCT03576638
Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
Start: Jul 31, 2018
Completion: Jan 31, 2019
NCT03646071
A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors
Start: Aug 1, 2018
Completion: Dec 31, 2023
NCT02987634
Evaluation and Comparison of Efficacy of PeriActive Mouthwash to Chlorhexidine 0.12% Mouth Rinse
Phase: Phase 4
Start: Dec 31, 2018
Completion: Feb 29, 2020
NCT04054414
PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord Injury
Start: Jan 10, 2019
Completion: Jul 31, 2026
NCT04045327
Efficacy of PMZ-2010 (Centhaquine) a Resuscitative Agent for Hypovolemic Shock
Start: Jan 31, 2019
Completion: Sep 27, 2019
NCT04047563
Efficacy of Sovateltide (PMZ-1620) in Patients of Acute Ischemic Stroke
Start: Nov 10, 2019
Completion: Feb 10, 2022
NCT04884217
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
Start: May 20, 2021
Completion: Dec 30, 2021
NCT05956418
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
Start: Aug 13, 2021
Completion: Dec 31, 2025
NCT05388630
Microbiome, Anxiety and Cognitive Orientation Study
Role: Collaborator
Start: Jun 1, 2022
Completion: May 30, 2023
NCT05659277
The Effects of Stress & Irregular Shift Hours on First Responders
Start: Oct 12, 2022
Completion: May 1, 2023
NCT05494437
Effect of PP-01 on Cannabis Withdrawal Syndrome
Start: Oct 27, 2022
Completion: Aug 21, 2023
NCT05910450
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
Start: Jun 21, 2023
Completion: Apr 30, 2025
NCT05914805
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
Start: Aug 17, 2023
Completion: Mar 31, 2025
NCT05514340
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
Start: Sep 6, 2023
NCT06101459
A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients
Start: Dec 1, 2023
Completion: Dec 31, 2028
NCT05527301
HEM1036 Phase 2 Study in Low Anterior Resection Syndrome
Start: Jan 1, 2024
Completion: Jan 1, 2026
NCT05955326
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Start: Jan 8, 2024
NCT05691244
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Start: Jul 24, 2025
Completion: Nov 30, 2026
NCT06344364
Digital Pathology and AI for Liver Outcomes in MASLD
Start: Sep 1, 2025
Completion: Mar 15, 2026
NCT06493253
Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)
Completion: Mar 1, 2026
NCT05251181
A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent
Start: Oct 31, 2025
Completion: Oct 31, 2026
NCT05241067
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS
Start: Dec 31, 2025
Completion: Dec 31, 2026